Patent · US Active

Methods for treating sleep apnea with combinations of atomoxetine and (R)-oxybutynin

US11911351B2 · kind B2 · utility

0Cited by

2References

25Claims

0Family size

Assignee

APNIMED, INC. (DELAWARE) · US

Inventors

Lawrence G. MILLER · Titusville, US
Barry Wohl · Cambridge, US
Walter Joseph Lunsmann · Harvard, US

Key dates

Filing date	Jan 30, 2019
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Oct 11, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In general, the invention relates to pharmaceutical compositions comprising (R)-oxybutynin and a norepinephrine reuptake inhibitor (NRI) and methods of treating Sleep Apnea comprising administering (R)-oxybutynin and a norepinephrine reuptake inhibitor (NRI). In some embodiments, the NRI is atomoxetine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.